Melatonin and testicular damage in busulfan treated mice

Mehri Mirhoseini1, Ghasem Saki2, Masoud Hemadi3

  • 1Department of Anatomy, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran.

Abstract

Insights

Melatonin, an antioxidant, was investigated for its protective effects on testicular function following chemotherapy. This study found that melatonin can ameliorate the damaging effects of busulfan on germ cells and spermatogenesis.

Area of Science:

  • Reproductive Biology
  • Toxicology
  • Oncology

Background:

  • Cancer treatments can cause infertility by damaging germ cells.
  • Melatonin is an antioxidant with potential protective effects on reproductive systems.

Purpose of the Study:

  • To investigate if melatonin can protect the testis from chemotherapy-induced toxicity.
  • To evaluate the antioxidant properties of melatonin in mitigating drug-induced testicular damage.

Main Methods:

  • Experimental study involving three groups of mice: control, busulfan-treated, and busulfan + melatonin-treated.
  • Busulfan was administered to induce testicular toxicity.
  • Melatonin was administered daily to assess its protective effects on testicular morphology and spermatogenesis.

Main Results:

  • Busulfan significantly reduced Johnson's criteria, seminiferous tubule diameter, and testicular epithelium height.
  • Melatonin administration partially reversed these negative effects, improving spermatogenesis and reducing apoptosis.
  • While melatonin showed protective effects, it did not completely eliminate all apoptotic cells.

Conclusions:

  • Melatonin demonstrates a protective effect against busulfan-induced testicular toxicity.
  • Melatonin ameliorates the cytotoxic impact of chemotherapy drugs on germ cells.
  • Further research may explore optimal melatonin dosages for cancer patients experiencing treatment-related infertility.

Related Concept Videos